全体要約
核酸はすべての細胞とウイルスにおいて重要な役割を果たす大きなバイオ分子です。核酸生物試薬は、生命科学研究や臨床診断、医療研究に使用される核酸に関連する生物材料や有機化合物を指します。2023年の核酸生物試薬の世界市場は11240百万米ドルと推定され、2030年には24200百万米ドルに達する見込みで、2024年から2030年の間に年平均成長率（CAGR）は10.5%です。
生命科学試薬は、生命科学研究の基本的な材料であり、広く消耗品として使用されています。Frost&Sullivanのデータによると、2015年の生物試薬の世界市場規模は128億米ドル、2019年には175億米ドルに達し、年平均成長率は8.1%です。このレポートは、核酸生物試薬の市場規模、売上高、価格、主要企業の市場シェアとランキングを分析し、地域別、タイプ別、用途別に詳細な情報を提供します。
関連する質問
11240百万米ドル（2023年）
10.5%（2024年-2030年）
Thermo Fisher, Qiagen, Takara, Bio-Rad, CWBIO, Abclonal Technology, Yeasen Biotechnology, PerkinElmer, Genscript, Novoprotein, Vazyme, TransGen Biotech
ライフサイエンス研究の需要増加, 医療診断の進展, 遺伝子編集技術の発展
概要
核酸生物試薬の世界市場は、2023年に112億4000万米ドルの価値があると推定され、2030年までに242億米ドルの調整後の規模に達することが予測されており、予測期間2024年から2030年にかけて年平均成長率（CAGR）は10.5%です。
ライフサイエンス試薬は、ライフサイエンスの研究開発における基本的な材料であり、ライフサイエンス研究活動で消耗品として広く使用されています。Frost＆Sullivanのデータによれば、2015年のバイオ試薬の世界市場規模は128億米ドル、2019年には175億米ドルに達し、年平均成長率は8.1%です。
報告の範囲
この報告書は、核酸生物試薬の世界市場に関する包括的なプレゼンテーションを提供することを目的としており、総販売量、売上高、価格、主要企業の市場シェアとランキング、地域別および国別、種類別、用途別の核酸生物試薬の分析を含みます。
核酸生物試薬市場の規模、推定、予測は、2023年を基準年として、販売数量（Kユニット）および販売収益（百万ドル）で提供されます。2019年から2030年までの歴史的データと予測データが含まれています。定量分析と定性分析の両方を用いて、読者がビジネス／成長戦略を策定し、市場の競争状況を評価し、現在の市場における自社の位置を分析し、核酸生物試薬に関する情報に基づいたビジネス決定を行うのを支援します。
市場セグメンテーション
会社別
サーモフィッシャー
キアゲン
タカラ
バイオラッド
CWBIO
Abclonalテクノロジー
イエイセンバイオテクノロジー
パーキンエルマー
ジェンスクリプト
ノボプロテイン
ヴァザイム
トランスジェンバイオテック
タイプ別セグメント:
カスタマイズ合成核酸
クローンキャリア
用途別セグメント
大学
製薬会社
その他
地域別
北アメリカ
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国 台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東およびアフリカ
トルコ
サウジアラビア
U.A.E. (アラブ首長国連邦)
章の概要
第1章：レポートの範囲、世界の総市場規模（バルブ、数量および価格）を紹介します。この章では、市場の動向、市場の最新の発展、推進要因および制約要因、業界における製造業者が直面する課題とリスク、ならびに業界に関連する政策の分析も提供されます。
第2章：核酸生物試薬メーカーの競争環境、価格、販売および収益市場シェア、最新の開発計画、合併および買収情報などの詳細分析です。
第3章：さまざまな市場セグメントのタイプ別分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーします。これにより、読者は異なる市場セグメントでブルーオーシャン市場を見つける手助けをします。
第4章：市場セグメント別のアプリケーションの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーしています。これにより、読者はさまざまな下流市場におけるブルーオーシャン市場を見つけることができます。
第5章：地域レベルにおける核酸生物試薬の販売および収益です。各地域の市場規模と成長可能性について定量分析を提供し、世界の各国の市場発展、将来の発展見通し、市場空間、および市場規模を紹介します。
第6章：国別のヌクレア酸生物試薬の売上と収益。タイプ別、アプリケーション別のシグマデータを各国/地域に提供します。
第7章：主要プレーヤーのプロフィールを提供し、市場の主要企業の基本的な状況を詳細に紹介します。これには、製品の販売、収益、価格、粗利、製品紹介、最近の開発などが含まれます。
第8章: 産業チェーンの分析、産業の上流と下流を含みます。
第9章：結論。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 市場概要
1.1 核酸生物試薬 : プロダクトのイントロダクション
1.2 グローバルの市場規模、市場予測
1.2.1 グローバルの核酸生物試薬売上規模、金額ベース（2019年～2030年）
1.2.2 グローバルの核酸生物試薬売上規模、数量ベース（2019年～2030年）
1.2.3 グローバルの核酸生物試薬市場、販売価格動向（2019年～2030年）
1.3 核酸生物試薬市場トレンドと成長ドライバー
1.3.1 核酸生物試薬業界トレンド
1.3.2 核酸生物試薬市場のドライバーと事業機会
1.3.3 核酸生物試薬市場の課題
1.3.4 核酸生物試薬市場の抑制要因
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 競合分析、企業別
2.1 グローバルの核酸生物試薬、プレイヤー収益ランキング（2023年）
2.2 グローバルにおける核酸生物試薬市場の収益規模、企業別（2019年～2024年）
2.3 グローバルの核酸生物試薬、プレイヤー売上数量ランキング（2023年）
2.4 グローバルの核酸生物試薬、売上数量（企業別）（2019年～2024年）
2.5 グローバルの核酸生物試薬の平均価格、企業別（2019年～2024年）
2.6 核酸生物試薬の主要メーカー、製造・販売拠点およびヘッドクオーター
2.7 核酸生物試薬の主要メーカー、製品展開
2.8 核酸生物試薬の主要メーカー、量産開始時期
2.9 核酸生物試薬市場の競争状況分析
2.9.1 核酸生物試薬市場集中度比率（2019年～2024年）
2.9.2 グローバルの核酸生物試薬、上位メーカー5～10社の収益（2023年）
2.9.3 グローバルの核酸生物試薬、企業タイプ別上位メーカー（Tier 1、Tier 2、Tier 3）、2023年の収益ベース
2.10 M&A、拡大
3 セグメンテーション、タイプ別
3.1 イントロダクション、タイプ別
3.1.1 カスタマイズされた合成核酸
3.1.2 クローンキャリア
3.2 グローバルの核酸生物試薬の売上規模、金額ベース、タイプ別
3.2.1 グローバルの核酸生物試薬の売上規模、金額ベース、タイプ別（2019年、2023年、2030年）
3.2.2 グローバルの核酸生物試薬の売上規模、金額ベース、タイプ別（2019年～2030年）
3.2.3 グローバルの核酸生物試薬の売上規模、金額ベース、タイプ別（%）（2019年～2030年）
3.3 グローバルの核酸生物試薬の売上規模、数量ベース、タイプ別
3.3.1 グローバルの核酸生物試薬の売上規模、数量ベース、タイプ別（2019年、2023年、2030年）
3.3.2 グローバルの核酸生物試薬の売上規模、数量ベース、タイプ別（2019年～2030年）
3.3.3 グローバルの核酸生物試薬の売上規模、数量ベース、タイプ別（%）（2019年～2030年）
3.4 グローバルの核酸生物試薬の平均価格、タイプ別（2019年～2030年）
4 セグメンテーション、用途別
4.1 イントロダクション、用途別
4.1.1 カレッジ
4.1.2 医薬品企業
4.1.3 その他
4.2 グローバルの核酸生物試薬の売上規模、金額ベース、用途別
4.2.1 グローバルの核酸生物試薬の売上規模、金額ベース、用途別（2019年、2023年、2030年）
4.2.2 グローバルの核酸生物試薬の売上規模、金額ベース、用途別（2019年～2030年）
4.2.3 グローバルの核酸生物試薬の売上規模、金額ベース、用途別（%）（2019年～2030年）
4.3 グローバルの核酸生物試薬の売上規模、数量ベース、用途別
4.3.1 グローバルの核酸生物試薬の売上規模、数量ベース、用途別（2019年、2023年、2030年）
4.3.2 グローバルの核酸生物試薬の売上規模、数量ベース、用途別（2019年～2030年）
4.3.3 グローバルの核酸生物試薬の売上規模、数量ベース、用途別（%）（2019年～2030年）
4.4 グローバルの核酸生物試薬の平均価格、用途別（2019年～2030年）
5 セグメンテーション、地域別
5.1 グローバルの核酸生物試薬の売上規模、金額ベース、地域別
5.2 グローバルの核酸生物試薬の売上規模、数量ベース、地域別
5.3 グローバルの核酸生物試薬の平均価格、地域別（2019年～2030年）
5.4 北米
5.4.1 北米の核酸生物試薬売上規模、金額ベース、2019年～2030年
5.4.2 北米の核酸生物試薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.5 ヨーロッパ
5.5.1 ヨーロッパの核酸生物試薬売上規模、金額ベース、2019年～2030年
5.5.2 ヨーロッパの核酸生物試薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.6 アジア太平洋
5.6.1 アジア太平洋の核酸生物試薬売上規模、金額ベース、2019年～2030年
5.6.2 アジア太平洋の核酸生物試薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.7 南米
5.7.1 南米の核酸生物試薬売上規模、金額ベース、2019年～2030年
5.7.2 南米の核酸生物試薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.8 中東・アフリカ
5.8.1 中東・アフリカの核酸生物試薬売上規模、金額ベース、2019年～2030年
5.8.2 中東・アフリカの核酸生物試薬の売上規模、金額ベース、国別（%）、2023年、2030年
6 主要国・地域によるセグメンテーション
6.1 主要国・地域の核酸生物試薬の売上成長トレンド、金額ベース（2019年、2023年、2030年）
6.2 主要国・地域の核酸生物試薬の売上、金額ベース
6.3 米国
6.4 ヨーロッパ
6.5 中国
6.6 日本
6.7 韓国
6.8 東南アジア
6.9 インド
7 企業プロファイル
7.1 Thermo Fisher
7.1.1 Thermo Fisher：企業情報
7.1.2 Thermo Fisherの紹介と事業概要
7.1.3 Thermo Fisher：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.1.4 Thermo Fisher：核酸生物試薬分野の提供製品
7.1.5 Thermo Fisher直近の動向
7.2 Qiagen
7.2.1 Qiagen：企業情報
7.2.2 Qiagenの紹介と事業概要
7.2.3 Qiagen：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.2.4 Qiagen：核酸生物試薬分野の提供製品
7.2.5 Qiagen直近の動向
7.3 Takara
7.3.1 Takara：企業情報
7.3.2 Takaraの紹介と事業概要
7.3.3 Takara：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.3.4 Takara：核酸生物試薬分野の提供製品
7.3.5 Takara直近の動向
7.4 Bio-Rad
7.4.1 Bio-Rad：企業情報
7.4.2 Bio-Radの紹介と事業概要
7.4.3 Bio-Rad：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.4.4 Bio-Rad：核酸生物試薬分野の提供製品
7.4.5 Bio-Rad直近の動向
7.5 CWBIO
7.5.1 CWBIO：企業情報
7.5.2 CWBIOの紹介と事業概要
7.5.3 CWBIO：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.5.4 CWBIO：核酸生物試薬分野の提供製品
7.5.5 CWBIO直近の動向
7.6 Abclonal Technology
7.6.1 Abclonal Technology：企業情報
7.6.2 Abclonal Technologyの紹介と事業概要
7.6.3 Abclonal Technology：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.6.4 Abclonal Technology：核酸生物試薬分野の提供製品
7.6.5 Abclonal Technology直近の動向
7.7 Yeasen Biotechnology
7.7.1 Yeasen Biotechnology：企業情報
7.7.2 Yeasen Biotechnologyの紹介と事業概要
7.7.3 Yeasen Biotechnology：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.7.4 Yeasen Biotechnology：核酸生物試薬分野の提供製品
7.7.5 Yeasen Biotechnology直近の動向
7.8 PerkinElmer
7.8.1 PerkinElmer：企業情報
7.8.2 PerkinElmerの紹介と事業概要
7.8.3 PerkinElmer：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.8.4 PerkinElmer：核酸生物試薬分野の提供製品
7.8.5 PerkinElmer直近の動向
7.9 Genscript
7.9.1 Genscript：企業情報
7.9.2 Genscriptの紹介と事業概要
7.9.3 Genscript：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.9.4 Genscript：核酸生物試薬分野の提供製品
7.9.5 Genscript直近の動向
7.10 Novoprotein
7.10.1 Novoprotein：企業情報
7.10.2 Novoproteinの紹介と事業概要
7.10.3 Novoprotein：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.10.4 Novoprotein：核酸生物試薬分野の提供製品
7.10.5 Novoprotein直近の動向
7.11 Vazyme
7.11.1 Vazyme：企業情報
7.11.2 Vazymeの紹介と事業概要
7.11.3 Vazyme：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.11.4 Vazyme：核酸生物試薬分野の提供製品
7.11.5 Vazyme直近の動向
7.12 TransGen Biotech
7.12.1 TransGen Biotech：企業情報
7.12.2 TransGen Biotechの紹介と事業概要
7.12.3 TransGen Biotech：核酸生物試薬の売上、収益および売上総利益率（2019年〜2024年）
7.12.4 TransGen Biotech：核酸生物試薬分野の提供製品
7.12.5 TransGen Biotech直近の動向
8 業界チェーン分析
8.1 核酸生物試薬業界バリューチェーン
8.2 核酸生物試薬市場の上流分析
8.2.1 主要原材料
8.2.2 原材料と主要サプライヤー
8.2.3 製造コスト構造
8.3 中流分析
8.4 下流分析（顧客についての分析）
8.5 営業販売モデル、販売チャネル
8.5.1 核酸生物試薬 営業販売モデル
8.5.2 販売チャネル
8.5.3 核酸生物試薬の流通業者
9 調査の結果・結論
10 付録
10.1 調査手法
10.1.1 調査手法 / 調査アプローチ
10.1.2 データソース
10.2 執筆者の詳細
10.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The global market for Nucleic Acid Biological Reagent was estimated to be worth US$ 11240 million in 2023 and is forecast to a readjusted size of US$ 24200 million by 2030 with a CAGR of 10.5% during the forecast period 2024-2030
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan's data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Biological Reagent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nucleic Acid Biological Reagent by region & country, by Type, and by Application.
The Nucleic Acid Biological Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Biological Reagent.
Market Segmentation
By Company
Thermo Fisher
Qiagen
Takara
Bio-Rad
CWBIO
Abclonal Technology
Yeasen Biotechnology
PerkinElmer
Genscript
Novoprotein
Vazyme
TransGen Biotech
Segment by Type:
Customized Synthetic Nucleic Acid
Cloning Carrier
Segment by Application
College
Pharmaceutical Company
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nucleic Acid Biological Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nucleic Acid Biological Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nucleic Acid Biological Reagent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Nucleic Acid Biological Reagent Product Introduction
1.2 Global Nucleic Acid Biological Reagent Market Size Forecast
1.2.1 Global Nucleic Acid Biological Reagent Sales Value (2019-2030)
1.2.2 Global Nucleic Acid Biological Reagent Sales Volume (2019-2030)
1.2.3 Global Nucleic Acid Biological Reagent Sales Price (2019-2030)
1.3 Nucleic Acid Biological Reagent Market Trends & Drivers
1.3.1 Nucleic Acid Biological Reagent Industry Trends
1.3.2 Nucleic Acid Biological Reagent Market Drivers & Opportunity
1.3.3 Nucleic Acid Biological Reagent Market Challenges
1.3.4 Nucleic Acid Biological Reagent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nucleic Acid Biological Reagent Players Revenue Ranking (2023)
2.2 Global Nucleic Acid Biological Reagent Revenue by Company (2019-2024)
2.3 Global Nucleic Acid Biological Reagent Players Sales Volume Ranking (2023)
2.4 Global Nucleic Acid Biological Reagent Sales Volume by Company Players (2019-2024)
2.5 Global Nucleic Acid Biological Reagent Average Price by Company (2019-2024)
2.6 Key Manufacturers Nucleic Acid Biological Reagent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nucleic Acid Biological Reagent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nucleic Acid Biological Reagent
2.9 Nucleic Acid Biological Reagent Market Competitive Analysis
2.9.1 Nucleic Acid Biological Reagent Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nucleic Acid Biological Reagent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Biological Reagent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Customized Synthetic Nucleic Acid
3.1.2 Cloning Carrier
3.2 Global Nucleic Acid Biological Reagent Sales Value by Type
3.2.1 Global Nucleic Acid Biological Reagent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nucleic Acid Biological Reagent Sales Value, by Type (2019-2030)
3.2.3 Global Nucleic Acid Biological Reagent Sales Value, by Type (%) (2019-2030)
3.3 Global Nucleic Acid Biological Reagent Sales Volume by Type
3.3.1 Global Nucleic Acid Biological Reagent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nucleic Acid Biological Reagent Sales Volume, by Type (2019-2030)
3.3.3 Global Nucleic Acid Biological Reagent Sales Volume, by Type (%) (2019-2030)
3.4 Global Nucleic Acid Biological Reagent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 College
4.1.2 Pharmaceutical Company
4.1.3 Others
4.2 Global Nucleic Acid Biological Reagent Sales Value by Application
4.2.1 Global Nucleic Acid Biological Reagent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nucleic Acid Biological Reagent Sales Value, by Application (2019-2030)
4.2.3 Global Nucleic Acid Biological Reagent Sales Value, by Application (%) (2019-2030)
4.3 Global Nucleic Acid Biological Reagent Sales Volume by Application
4.3.1 Global Nucleic Acid Biological Reagent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nucleic Acid Biological Reagent Sales Volume, by Application (2019-2030)
4.3.3 Global Nucleic Acid Biological Reagent Sales Volume, by Application (%) (2019-2030)
4.4 Global Nucleic Acid Biological Reagent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nucleic Acid Biological Reagent Sales Value by Region
5.1.1 Global Nucleic Acid Biological Reagent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nucleic Acid Biological Reagent Sales Value by Region (2019-2024)
5.1.3 Global Nucleic Acid Biological Reagent Sales Value by Region (2025-2030)
5.1.4 Global Nucleic Acid Biological Reagent Sales Value by Region (%), (2019-2030)
5.2 Global Nucleic Acid Biological Reagent Sales Volume by Region
5.2.1 Global Nucleic Acid Biological Reagent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nucleic Acid Biological Reagent Sales Volume by Region (2019-2024)
5.2.3 Global Nucleic Acid Biological Reagent Sales Volume by Region (2025-2030)
5.2.4 Global Nucleic Acid Biological Reagent Sales Volume by Region (%), (2019-2030)
5.3 Global Nucleic Acid Biological Reagent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nucleic Acid Biological Reagent Sales Value, 2019-2030
5.4.2 North America Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nucleic Acid Biological Reagent Sales Value, 2019-2030
5.5.2 Europe Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nucleic Acid Biological Reagent Sales Value, 2019-2030
5.6.2 Asia Pacific Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nucleic Acid Biological Reagent Sales Value, 2019-2030
5.7.2 South America Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nucleic Acid Biological Reagent Sales Value, 2019-2030
5.8.2 Middle East & Africa Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nucleic Acid Biological Reagent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nucleic Acid Biological Reagent Sales Value
6.2.1 Key Countries/Regions Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nucleic Acid Biological Reagent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.3.2 United States Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.4.2 Europe Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.5.2 China Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.6.2 Japan Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.7.2 South Korea Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.8.2 Southeast Asia Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nucleic Acid Biological Reagent Sales Value, 2019-2030
6.9.2 India Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nucleic Acid Biological Reagent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Introduction and Business Overview
7.1.3 Thermo Fisher Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Nucleic Acid Biological Reagent Product Offerings
7.1.5 Thermo Fisher Recent Development
7.2 Qiagen
7.2.1 Qiagen Company Information
7.2.2 Qiagen Introduction and Business Overview
7.2.3 Qiagen Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Qiagen Nucleic Acid Biological Reagent Product Offerings
7.2.5 Qiagen Recent Development
7.3 Takara
7.3.1 Takara Company Information
7.3.2 Takara Introduction and Business Overview
7.3.3 Takara Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Takara Nucleic Acid Biological Reagent Product Offerings
7.3.5 Takara Recent Development
7.4 Bio-Rad
7.4.1 Bio-Rad Company Information
7.4.2 Bio-Rad Introduction and Business Overview
7.4.3 Bio-Rad Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bio-Rad Nucleic Acid Biological Reagent Product Offerings
7.4.5 Bio-Rad Recent Development
7.5 CWBIO
7.5.1 CWBIO Company Information
7.5.2 CWBIO Introduction and Business Overview
7.5.3 CWBIO Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CWBIO Nucleic Acid Biological Reagent Product Offerings
7.5.5 CWBIO Recent Development
7.6 Abclonal Technology
7.6.1 Abclonal Technology Company Information
7.6.2 Abclonal Technology Introduction and Business Overview
7.6.3 Abclonal Technology Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Abclonal Technology Nucleic Acid Biological Reagent Product Offerings
7.6.5 Abclonal Technology Recent Development
7.7 Yeasen Biotechnology
7.7.1 Yeasen Biotechnology Company Information
7.7.2 Yeasen Biotechnology Introduction and Business Overview
7.7.3 Yeasen Biotechnology Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Yeasen Biotechnology Nucleic Acid Biological Reagent Product Offerings
7.7.5 Yeasen Biotechnology Recent Development
7.8 PerkinElmer
7.8.1 PerkinElmer Company Information
7.8.2 PerkinElmer Introduction and Business Overview
7.8.3 PerkinElmer Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.8.4 PerkinElmer Nucleic Acid Biological Reagent Product Offerings
7.8.5 PerkinElmer Recent Development
7.9 Genscript
7.9.1 Genscript Company Information
7.9.2 Genscript Introduction and Business Overview
7.9.3 Genscript Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Genscript Nucleic Acid Biological Reagent Product Offerings
7.9.5 Genscript Recent Development
7.10 Novoprotein
7.10.1 Novoprotein Company Information
7.10.2 Novoprotein Introduction and Business Overview
7.10.3 Novoprotein Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novoprotein Nucleic Acid Biological Reagent Product Offerings
7.10.5 Novoprotein Recent Development
7.11 Vazyme
7.11.1 Vazyme Company Information
7.11.2 Vazyme Introduction and Business Overview
7.11.3 Vazyme Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Vazyme Nucleic Acid Biological Reagent Product Offerings
7.11.5 Vazyme Recent Development
7.12 TransGen Biotech
7.12.1 TransGen Biotech Company Information
7.12.2 TransGen Biotech Introduction and Business Overview
7.12.3 TransGen Biotech Nucleic Acid Biological Reagent Sales, Revenue and Gross Margin (2019-2024)
7.12.4 TransGen Biotech Nucleic Acid Biological Reagent Product Offerings
7.12.5 TransGen Biotech Recent Development
8 Industry Chain Analysis
8.1 Nucleic Acid Biological Reagent Industrial Chain
8.2 Nucleic Acid Biological Reagent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nucleic Acid Biological Reagent Sales Model
8.5.2 Sales Channel
8.5.3 Nucleic Acid Biological Reagent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Nucleic Acid Biological Reagent Market Trends Table 2. Nucleic Acid Biological Reagent Market Drivers & Opportunity Table 3. Nucleic Acid Biological Reagent Market Challenges Table 4. Nucleic Acid Biological Reagent Market Restraints Table 5. Global Nucleic Acid Biological Reagent Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Nucleic Acid Biological Reagent Revenue Market Share by Company (2019-2024) Table 7. Global Nucleic Acid Biological Reagent Sales Volume by Company (2019-2024) & (K Units) Table 8. Global Nucleic Acid Biological Reagent Sales Volume Market Share by Company (2019-2024) Table 9. Global Market Nucleic Acid Biological Reagent Price by Company (2019-2024) & (US$/Unit) Table 10. Key Manufacturers Nucleic Acid Biological Reagent Manufacturing Base Distribution and Headquarters Table 11. Key Manufacturers Nucleic Acid Biological Reagent Product Type Table 12. Key Manufacturers Time to Begin Mass Production of Nucleic Acid Biological Reagent Table 13. Global Nucleic Acid Biological Reagent Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Biological Reagent as of 2023) Table 15. Mergers & Acquisitions, Expansion Plans Table 16. Global Nucleic Acid Biological Reagent Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 17. Global Nucleic Acid Biological Reagent Sales Value by Type (2019-2024) & (US$ Million) Table 18. Global Nucleic Acid Biological Reagent Sales Value by Type (2025-2030) & (US$ Million) Table 19. Global Nucleic Acid Biological Reagent Sales Market Share in Value by Type (2019-2024) & (%) Table 20. Global Nucleic Acid Biological Reagent Sales Market Share in Value by Type (2025-2030) & (%) Table 21. Global Nucleic Acid Biological Reagent Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units) Table 22. Global Nucleic Acid Biological Reagent Sales Volume by Type (2019-2024) & (K Units) Table 23. Global Nucleic Acid Biological Reagent Sales Volume by Type (2025-2030) & (K Units) Table 24. Global Nucleic Acid Biological Reagent Sales Market Share in Volume by Type (2019-2024) & (%) Table 25. Global Nucleic Acid Biological Reagent Sales Market Share in Volume by Type (2025-2030) & (%) Table 26. Global Nucleic Acid Biological Reagent Price by Type (2019-2024) & (US$/Unit) Table 27. Global Nucleic Acid Biological Reagent Price by Type (2025-2030) & (US$/Unit) Table 28. Global Nucleic Acid Biological Reagent Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 29. Global Nucleic Acid Biological Reagent Sales Value by Application (2019-2024) & (US$ Million) Table 30. Global Nucleic Acid Biological Reagent Sales Value by Application (2025-2030) & (US$ Million) Table 31. Global Nucleic Acid Biological Reagent Sales Market Share in Value by Application (2019-2024) & (%) Table 32. Global Nucleic Acid Biological Reagent Sales Market Share in Value by Application (2025-2030) & (%) Table 33. Global Nucleic Acid Biological Reagent Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units) Table 34. Global Nucleic Acid Biological Reagent Sales Volume by Application (2019-2024) & (K Units) Table 35. Global Nucleic Acid Biological Reagent Sales Volume by Application (2025-2030) & (K Units) Table 36. Global Nucleic Acid Biological Reagent Sales Market Share in Volume by Application (2019-2024) & (%) Table 37. Global Nucleic Acid Biological Reagent Sales Market Share in Volume by Application (2025-2030) & (%) Table 38. Global Nucleic Acid Biological Reagent Price by Application (2019-2024) & (US$/Unit) Table 39. Global Nucleic Acid Biological Reagent Price by Application (2025-2030) & (US$/Unit) Table 40. Global Nucleic Acid Biological Reagent Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 41. Global Nucleic Acid Biological Reagent Sales Value by Region (2019-2024) & (US$ Million) Table 42. Global Nucleic Acid Biological Reagent Sales Value by Region (2025-2030) & (US$ Million) Table 43. Global Nucleic Acid Biological Reagent Sales Value by Region (2019-2024) & (%) Table 44. Global Nucleic Acid Biological Reagent Sales Value by Region (2025-2030) & (%) Table 45. Global Nucleic Acid Biological Reagent Sales Volume by Region (K Units): 2019 VS 2023 VS 2030 Table 46. Global Nucleic Acid Biological Reagent Sales Volume by Region (2019-2024) & (K Units) Table 47. Global Nucleic Acid Biological Reagent Sales Volume by Region (2025-2030) & (K Units) Table 48. Global Nucleic Acid Biological Reagent Sales Volume by Region (2019-2024) & (%) Table 49. Global Nucleic Acid Biological Reagent Sales Volume by Region (2025-2030) & (%) Table 50. Global Nucleic Acid Biological Reagent Average Price by Region (2019-2024) & (US$/Unit) Table 51. Global Nucleic Acid Biological Reagent Average Price by Region (2025-2030) & (US$/Unit) Table 52. Key Countries/Regions Nucleic Acid Biological Reagent Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 53. Key Countries/Regions Nucleic Acid Biological Reagent Sales Value, (2019-2024) & (US$ Million) Table 54. Key Countries/Regions Nucleic Acid Biological Reagent Sales Value, (2025-2030) & (US$ Million) Table 55. Key Countries/Regions Nucleic Acid Biological Reagent Sales Volume, (2019-2024) & (K Units) Table 56. Key Countries/Regions Nucleic Acid Biological Reagent Sales Volume, (2025-2030) & (K Units) Table 57. Thermo Fisher Company Information Table 58. Thermo Fisher Introduction and Business Overview Table 59. Thermo Fisher Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 60. Thermo Fisher Nucleic Acid Biological Reagent Product Offerings Table 61. Thermo Fisher Recent Development Table 62. Qiagen Company Information Table 63. Qiagen Introduction and Business Overview Table 64. Qiagen Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 65. Qiagen Nucleic Acid Biological Reagent Product Offerings Table 66. Qiagen Recent Development Table 67. Takara Company Information Table 68. Takara Introduction and Business Overview Table 69. Takara Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 70. Takara Nucleic Acid Biological Reagent Product Offerings Table 71. Takara Recent Development Table 72. Bio-Rad Company Information Table 73. Bio-Rad Introduction and Business Overview Table 74. Bio-Rad Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 75. Bio-Rad Nucleic Acid Biological Reagent Product Offerings Table 76. Bio-Rad Recent Development Table 77. CWBIO Company Information Table 78. CWBIO Introduction and Business Overview Table 79. CWBIO Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 80. CWBIO Nucleic Acid Biological Reagent Product Offerings Table 81. CWBIO Recent Development Table 82. Abclonal Technology Company Information Table 83. Abclonal Technology Introduction and Business Overview Table 84. Abclonal Technology Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 85. Abclonal Technology Nucleic Acid Biological Reagent Product Offerings Table 86. Abclonal Technology Recent Development Table 87. Yeasen Biotechnology Company Information Table 88. Yeasen Biotechnology Introduction and Business Overview Table 89. Yeasen Biotechnology Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 90. Yeasen Biotechnology Nucleic Acid Biological Reagent Product Offerings Table 91. Yeasen Biotechnology Recent Development Table 92. PerkinElmer Company Information Table 93. PerkinElmer Introduction and Business Overview Table 94. PerkinElmer Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 95. PerkinElmer Nucleic Acid Biological Reagent Product Offerings Table 96. PerkinElmer Recent Development Table 97. Genscript Company Information Table 98. Genscript Introduction and Business Overview Table 99. Genscript Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 100. Genscript Nucleic Acid Biological Reagent Product Offerings Table 101. Genscript Recent Development Table 102. Novoprotein Company Information Table 103. Novoprotein Introduction and Business Overview Table 104. Novoprotein Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 105. Novoprotein Nucleic Acid Biological Reagent Product Offerings Table 106. Novoprotein Recent Development Table 107. Vazyme Company Information Table 108. Vazyme Introduction and Business Overview Table 109. Vazyme Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 110. Vazyme Nucleic Acid Biological Reagent Product Offerings Table 111. Vazyme Recent Development Table 112. TransGen Biotech Company Information Table 113. TransGen Biotech Introduction and Business Overview Table 114. TransGen Biotech Nucleic Acid Biological Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 115. TransGen Biotech Nucleic Acid Biological Reagent Product Offerings Table 116. TransGen Biotech Recent Development Table 117. Key Raw Materials Lists Table 118. Raw Materials Key Suppliers Lists Table 119. Nucleic Acid Biological Reagent Downstream Customers Table 120. Nucleic Acid Biological Reagent Distributors List Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Nucleic Acid Biological Reagent Product Picture Figure 2. Global Nucleic Acid Biological Reagent Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Nucleic Acid Biological Reagent Sales Value (2019-2030) & (US$ Million) Figure 4. Global Nucleic Acid Biological Reagent Sales Volume (2019-2030) & (K Units) Figure 5. Global Nucleic Acid Biological Reagent Sales Price (2019-2030) & (US$/Unit) Figure 6. Nucleic Acid Biological Reagent Report Years Considered Figure 7. Global Nucleic Acid Biological Reagent Players Revenue Ranking (2023) & (US$ Million) Figure 8. Global Nucleic Acid Biological Reagent Players Sales Volume Ranking (2023) & (K Units) Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Acid Biological Reagent Revenue in 2023 Figure 10. Nucleic Acid Biological Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 11. Customized Synthetic Nucleic Acid Picture Figure 12. Cloning Carrier Picture Figure 13. Global Nucleic Acid Biological Reagent Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 14. Global Nucleic Acid Biological Reagent Sales Value Market Share by Type, 2023 & 2030 Figure 15. Global Nucleic Acid Biological Reagent Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units) Figure 16. Global Nucleic Acid Biological Reagent Sales Volume Market Share by Type, 2023 & 2030 Figure 17. Global Nucleic Acid Biological Reagent Price by Type (2019-2030) & (US$/Unit) Figure 18. Product Picture of College Figure 19. Product Picture of Pharmaceutical Company Figure 20. Product Picture of Others Figure 21. Global Nucleic Acid Biological Reagent Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 22. Global Nucleic Acid Biological Reagent Sales Value Market Share by Application, 2023 & 2030 Figure 23. Global Nucleic Acid Biological Reagent Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units) Figure 24. Global Nucleic Acid Biological Reagent Sales Volume Market Share by Application, 2023 & 2030 Figure 25. Global Nucleic Acid Biological Reagent Price by Application (2019-2030) & (US$/Unit) Figure 26. North America Nucleic Acid Biological Reagent Sales Value (2019-2030) & (US$ Million) Figure 27. North America Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030 Figure 28. Europe Nucleic Acid Biological Reagent Sales Value (2019-2030) & (US$ Million) Figure 29. Europe Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030 Figure 30. Asia Pacific Nucleic Acid Biological Reagent Sales Value (2019-2030) & (US$ Million) Figure 31. Asia Pacific Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030 Figure 32. South America Nucleic Acid Biological Reagent Sales Value (2019-2030) & (US$ Million) Figure 33. South America Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030 Figure 34. Middle East & Africa Nucleic Acid Biological Reagent Sales Value (2019-2030) & (US$ Million) Figure 35. Middle East & Africa Nucleic Acid Biological Reagent Sales Value by Country (%), 2023 VS 2030 Figure 36. Key Countries/Regions Nucleic Acid Biological Reagent Sales Value (%), (2019-2030) Figure 37. Key Countries/Regions Nucleic Acid Biological Reagent Sales Volume (%), (2019-2030) Figure 38. United States Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 39. United States Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 40. United States Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 41. Europe Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 42. Europe Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 43. Europe Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 44. China Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 45. China Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 46. China Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 47. Japan Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 48. Japan Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 49. Japan Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 50. South Korea Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 51. South Korea Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 52. South Korea Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 53. Southeast Asia Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 54. Southeast Asia Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 55. Southeast Asia Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 56. India Nucleic Acid Biological Reagent Sales Value, (2019-2030) & (US$ Million) Figure 57. India Nucleic Acid Biological Reagent Sales Value by Type (%), 2023 VS 2030 Figure 58. India Nucleic Acid Biological Reagent Sales Value by Application (%), 2023 VS 2030 Figure 59. Nucleic Acid Biological Reagent Industrial Chain Figure 60. Nucleic Acid Biological Reagent Manufacturing Cost Structure Figure 61. Channels of Distribution (Direct Sales, and Distribution) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed
